Attached files

file filename
EX-32.2 - EXHIBIT 32.2 - XBiotech Inc.ex_233704.htm
EX-31.2 - EXHIBIT 31.2 - XBiotech Inc.ex_233702.htm
EX-31.1 - EXHIBIT 31.1 - XBiotech Inc.ex_233701.htm
EX-23.1 - EXHIBIT 23.1 - XBiotech Inc.ex_233700.htm
EX-21.1 - EXHIBIT 21.1 - XBiotech Inc.ex_233699.htm
EX-4.1 - EXHIBIT 4.1 - XBiotech Inc.ex_233697.htm
10-K - FORM 10-K - XBiotech Inc.xbit20201231_10k.htm

Exhibit 32.1

 

CERTIFICATION PURSUANT TO  18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of XBiotech Inc. on Form 10-K for the period ended December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John Simard, Chief Executive Officer and President of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of XBiotech Inc.

 

  /S/ JOHN SIMARD  
  John Simard  
  Chief Executive Officer and President  
  (Principal Executive Officer)  
  Date:  March 16, 2021